Show simple item record

dc.contributor.authorSinclair, Diarmid J. M.
dc.contributor.authorAdams, Clive E.
dc.date.accessioned2018-03-07T13:31:21Z
dc.date.available2018-03-07T13:31:21Z
dc.date.issued2015
dc.identifier.citationSinclair, D. J. M., Ellison, J. M. & Adams, C. E. (2015). Electroconvulsive therapy for treatment-resistant schizophrenia. Cochrane Database of Systematic Reviews, (9), pp.CD011847.en
dc.identifier.other10.1002/14651858.CD011847
dc.identifier.urihttp://hdl.handle.net/20.500.12904/9829
dc.description.abstractThis is the protocol for a review and there is no abstract. The objectives are as follows: Our primary objective is to assess the effects (benefits and harms) of ECT for people with treatment-resistant schizophrenia. Our secondary objectives are to determine whether ECT produces a differential response in people: who are treated with unilateral compared to bilateral ECT; who have had a long course of ECT (more than 12 sessions) or short course of ECT; who are given continuation or maintenance ECT; who are diagnosed with well defined treatment resistant schizophrenia as opposed to less rigorously defined treatment-resistant schizophrenia (who would be expected to have a greater affective component to their illness).<br/>Copyright &#xa9; 2015 The Cochrane Collaboration.en
dc.description.urihttp://onlinelibrary.wiley.com/doi/10.1002/14651858.CD011847/full
dc.formatFull text uploaded
dc.subjectDiagnosisen
dc.subjectElectroconvulsive therapyen
dc.subjectSchizophreniaen
dc.titleElectroconvulsive therapy for treatment-resistant schizophreniaen
dc.typeArticleen
refterms.dateFOA2021-06-14T11:07:51Z


Files in this item

Thumbnail
Name:
Sinclair 2015 1-14.pdf
Size:
244.6Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record